Josep Ramón Germà-Lluch

Author

Also Known As

J Germà-Lluch, J. R. Germà-Lluch, J. R. Germá-Lluch, J.R. Germa-Lluch, J.R. Germà-Lluch, J.R. Germá-Lluch, Josep R. Germá-Lluch, Josep Ramon Germa-Lluch, Josep Ramon Germà-Lluch, Josep Ramón Germà-Lluch

Publications

420

Citations

H-Index

Concepts

All Affiliations

Institut Català d'Oncologia Institut d'Investigació Biomédica de Bellvitge Hospital de Sant Pau Hospital Universitari Sant Joan de Reus Duran i Reynals Hospital

About

Josep Ramón Germà-Lluch is an author at Institut Català d'Oncologia specializing in oncology, cancer research, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	224
2	Pathology	2	2	183
3	Obstetrics	1	1	26
4	Pharmacology	1	1	15
5	Surgical Oncology	1	1	26

Josep Ramón Germà-Lluch

Publications

404

Citations

H-Index

Page 1

	Year	Citations
Clinical Pattern and Therapeutic Results Achieved in 1490 Patients with Germ-Cell Tumours of the Testis: the Experience of the Spanish Germ-Cell Cancer Group (GG) Josep Ramón Germà-Lluch European Urology Germ CellMedicineCancer ManagementTherapeutic Results AchievedPathology	2002	151
Chemotherapy As an Alternative to Radiotherapy in the Treatment of Stage IIA and IIB Testicular Seminoma: A Spanish Germ Cell Cancer Group Study Xavier García del Muro, Pablo Maroto, Josep Gumà, Journal of Clinical Oncology	2008	135
E400P in advanced seminoma of good prognosis according to the International Germ Cell Cancer Collaborative Group (IGCCCG) classification: The Spanish Germ Cell Cancer Group experience J.Á. Arranz Arija, Xavier García del Muro, Josep Gumà, Annals of Oncology Genitourinary CancerGood PrognosisMedicineAdvanced SeminomaCancer Management	2001	32
SEOM clinical guidelines for the management of germ cell testicular cancer (2016) Jorge Aparicio, Josefa Terrasa, Ignacio Durán, Clinical & Translational Oncology Surgical OncologyUrologyGerm CellGenitourinary CancerMedicine	2016	26
Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma Margarita García, Xavier García del Muro, A. Trés, Melanoma Research	2006	17
A phase I clinical and pharmacokinetic study of paclitaxel and docetaxel given in combination in patients with solid tumours Miguel Izquierdo, Margarita García, José Luis Pontón, European Journal of Cancer OncologyPharmacologySolid TumoursPharmacokinetic StudyPharmacotherapy	2006	15
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study A. Psyrri, Catherine Fortpied, George Koutsodontis, Annals of Oncology	2017	15
A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study Jorge Aparicio, Alfonso Sánchez‐Muñoz, Josep Gumà, Oncology	2018	13

Page 1